Hiromi Murakami

Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad

Y. Ohshima, T. Sugino, H. Kamada, 2006, Brain Tumor Pathology.

Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo

H. Kamada, H. Sawa, S. Yamauchi, 2004, Acta Neuropathologica.

A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings

K. Moriyama, H. Kamada, H. Nishihara, 2009, Journal of Neuro-Oncology.

Antitumor effects of a cyclooxygenase-2 inhibitor, meloxicam, alone and in combination with radiation and/or 5-fluorouracil in cultured tumor cells.

Y. Shibamoto, H. Ogino, S. Ayakawa, 2009, Molecular medicine reports.

Host-dependent roles of the viral 5' untranslated region (UTR) in RNA stabilization and cap-independent translational enhancement mediated by the 3' UTR of Red clover necrotic mosaic virus RNA1.

K. Mise, T. Okuno, M. Kaido, 2009, Virology.

Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner

H. Kamada, M. Hara, H. Sawa, 1998, Oncogene.

Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells

T. Mima, H. Kamada, H. Sawa, 2006, Brain Tumor Pathology.